Global Point of Care (PoC) Testing Market By Product (Testing Type) (Glucose monitoring, Cardiometabolic Monitoring, Albumin Testing, Infectious disease testing – HIV Infections, Malaria, Syphilis, E. Coli, Influenza, Others, Coagulation monitoring, Pregnancy and fertility testing, Cancer marker testing, Urine analysis testing, Cholesterol testing, Hematology testing, Drugs-of-abuse testing, Fecal Occult testing, Covid-19 testing, Others); By Distribution Channel (Prescription Based, Over The Counter (OTC)); By End-user (Hospitals – Critical Care Units, Neonatal Intensive Care Unit (NICU), Others, Private Clinics, Diagnostic Centres, Home Care Settings, Ambulatory Care Centers, Emergency Departments, Laboratories, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030